ReviewInternational journal of clinical oncology2020

Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment.

Hiro Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.